天弘医药创新C(010655)资产负债表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
209.57 |
231,387.18 |
1,523,628.80 |
0.01 |
| 存出保证金 |
402,216.77 |
343,508.37 |
309,679.37 |
462,104.52 |
| 交易性金融资产 |
1,092,848,790.26 |
923,262,340.85 |
753,560,753.96 |
998,448,678.03 |
| 其中：股票投资 |
1,092,848,790.26 |
923,262,340.85 |
753,560,753.96 |
998,448,678.03 |
| 债券投资 |
- |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
- |
45,415.57 |
91,268.52 |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
1,083,218.92 |
1,193,856.85 |
506,614.49 |
1,165,312.09 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
1,166,293,217.28 |
988,149,937.70 |
861,714,959.67 |
1,109,087,553.72 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
192.92 |
211.82 |
3,273.85 |
3,182,608.68 |
| 应付赎回款 |
4,835,270.74 |
7,602,700.53 |
913,855.16 |
2,606,827.31 |
| 应付管理人报酬 |
959,760.43 |
896,612.95 |
724,135.60 |
947,859.03 |
| 应付托管费 |
191,952.10 |
179,322.59 |
144,827.13 |
189,571.81 |
| 应付销售服务费 |
154,766.71 |
133,630.67 |
102,048.92 |
132,701.19 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
303,380.88 |
430,081.71 |
918,503.87 |
543,631.08 |
| 负债合计 |
6,445,323.78 |
9,242,560.27 |
2,806,644.53 |
7,603,199.10 |
| 所有者权益 |
| 实收基金 |
1,329,668,199.45 |
1,340,264,584.54 |
1,364,724,887.75 |
1,333,503,335.24 |
| 未分配利润 |
-169,820,305.95 |
-361,357,207.11 |
-505,816,572.61 |
-232,018,980.62 |
| 所有者权益合计 |
1,159,847,893.50 |
978,907,377.43 |
858,908,315.14 |
1,101,484,354.62 |
| 负债及所有者权益总计 |
1,166,293,217.28 |
988,149,937.70 |
861,714,959.67 |
1,109,087,553.72 |
欢迎访问证券之星！请点此与我们联系 版权所有： Copyright © 1996-年
微信公众号
证券之星APP
基本资料
